
Hot Topics in Infection and Immunity in Children II
Springer (Publisher)
Published on 21. June 2005
Book
Hardback
XXX, 234 pages
978-0-387-25341-1 (ISBN)
Description
Hot Topics in Infection and Immunity II provides a current view from leading experts concerning the hottest topics of concern to clinicians caring for children with infections. The book brings together a collection of manuscripts from a faculty of authors of international standing who contributed to a course in Paediatric Infection and Immunity in Oxford, UK in June 2004.
More details
Series
Edition
2005 ed.
Language
English
Place of publication
New York
United States
Target group
Professional and scholarly
Research
Product notice
sewn/stitched
Cloth over boards
Illustrations
27 s/w Abbildungen
XXX, 234 p. 27 illus.
Dimensions
Height: 241 mm
Width: 160 mm
Thickness: 20 mm
Weight
571 gr
ISBN-13
978-0-387-25341-1 (9780387253411)
DOI
10.1007/b107202
Schweitzer Classification
Other editions
Additional editions

Andrew J. Pollard | Adam Finn
Hot Topics in Infection and Immunity in Children II
Book
12/2010
Springer
€212.50
Shipment within 15-20 days

Andrew J. Pollard | Adam Finn
Hot Topics in Infection and Immunity in Children II
E-Book
04/2007
1st Edition
Springer
€213.99
Available for download
Content
Emerging Infections and Children: Influenza and Acute Necrotizing Encephalopathy.- Chickenpox Party or Varicella Vaccine?.- The ABC of Epstein-Barr Virus Infections.- The Immune Response to Viral Lower Respiratory Tract Infection.- Chronic Granulomatous Disease: From Genetic Defect to Clinical Presentation.- Novel Primary Immunodeficiencies.- Periodic Fever.- BCG Vaccine.- Helminth Infections of Children: Prospects for Control.- Rabies on the Doorstep.- Prevention of Typhoid Fever.- Dexamethasone in the Treatment of Pediatric Bacterial Meningitis in Developing Countries: Is it Beneficial?.- Should Dexamethasone be Part of Routine Therapy of Bacterial Meningitis in Industrialised Countries?.- How to Interpret a CSF-The Art and the Science.- Reverse Vaccinology and Vaccines for Serogroup B Neisseria meningitidis.